In wild-type mice, the inhibition of uPAR reduces tumor growth by inhibiting fibroblast-induced angiogenesis [8], and in humans, uPAR can indirectly reduce the availability of vascular endothelial growth factor (VEGF), which is known to be involved in the angiogenetic processes of CSDH [9, 10]. Here, PLAUR is linked to neoplasm.